Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001104659-22-071915
Filing Date
2022-06-16
Accepted
2022-06-16 16:21:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-10/A tm2218675d1_f10a.htm F-10/A 197136
2 EXHIBIT 5.1 tm2218675d1_ex5-1.htm EX-5.1 4359
3 GRAPHIC f10img001.jpg GRAPHIC 9038
4 GRAPHIC f10img02.jpg GRAPHIC 18346
5 GRAPHIC image_001.jpg GRAPHIC 1128
6 GRAPHIC image_002.jpg GRAPHIC 1259
7 GRAPHIC image_003.jpg GRAPHIC 1300
  Complete submission text file 0001104659-22-071915.txt   245897
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10/A | Act: 33 | File No.: 333-265510 | Film No.: 221020840
SIC: 2834 Pharmaceutical Preparations